Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

IR@tangotx.com Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com. Investors and Media: Elizabeth Hickin BOSTON, May 27, 2025 ( ...